CLPT NASDAQ
ClearPoint Neuro, Inc.
1W: +2.5%
1M: -36.7%
3M: -31.5%
YTD: -30.9%
1Y: -60.8%
3Y: +99.8%
5Y: -47.2%
$9.69
+0.65 (+7.19%)
Weekly Expected Move ±13.7%
$7
$8
$9
$10
$12
Credit Risk of going bust: higher than 78% of companies Debt: 17.8% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the third-riskiest tenth, about 1 in 140 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.28 (down 97%), ClearPoint Neuro, Inc. would be worth roughly what it owes.
Total debt $63.9M against a stock market value of $295.6M.
Distance to default 2.73 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $25.3M (short-term plus half of long-term), stock volatility 88.8%; Altman Z -1.66. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.28 (down 97%), ClearPoint Neuro, Inc. would be worth roughly what it owes.
Total debt $63.9M against a stock market value of $295.6M.
Distance to default 2.73 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $25.3M (short-term plus half of long-term), stock volatility 88.8%; Altman Z -1.66. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
9 relationships9
As Filer
counterparties named
0
As Counterparty
mentioned by others
3
Rel. Types
2024-11-07
Earliest Filing
2026-01-05
Latest Filing
partner: 3
investor: 3
target: 3
Counterparties (Filed by CLPT)
9 relationshipsCompanies named in CLPT's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| CALW SA LLC | — | partner | Purchaser Agent for the Note Purchase Agreement | 2026-01-05 | View |
| TPC Investments III LP | — | investor | 2025 Investor purchasing notes in a Third Sale | 2026-01-05 | View |
| Oberland Capital Management LLC | — | investor | Affiliate of the 2025 Investor | 2026-01-05 | View |
| IRRAS Holdings, Inc. | — | target | Target of the Company's acquisition | 2026-01-05 | View |
| IRRAS AB | — | partner | Swedish subsidiary involved in internal reorganization | 2026-01-05 | View |
| IRRAS Holdings, Inc. | — | target | Target company acquired by ClearPoint Neuro, Inc. in a merger transaction. | 2025-11-20 | View |
| IRRAS Holdings, Inc. | — | target | Target company in a merger agreement with ClearPoint Neuro, Inc. | 2025-11-06 | View |
| TPC INVESTMENTS III LP | — | investor | Investor in the registered direct offering of common stock | 2025-05-12 | View |
| Stifel, Nicolaus & Company, Incorporated | — | partner | Sales agent for the At-The-Market Equity Offering | 2024-11-07 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-08-03 | Earnings Release; Regulation FD; Exhibits | View | |
| 2026-05-21 | Officer/Director Change; Shareholder Vote; Exhibits | View | |
| 2026-05-13 | Earnings Release; Regulation FD; Exhibits | View | |
| 2026-03-17 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2026-02-05 | Financial Statements and Exhibits | View | |
| 2026-01-12 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2026-01-05 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation | Agreement | View |
| 2025-11-20 | Entry into Material Definitive Agreement; Completion of Acquisition or Disposition of Assets; Unregi | Agreement Acquisition | View |
| 2025-11-06 | Entry into Material Definitive Agreement; Regulation FD Disclosure; Financial Statements and Exhibit | Agreement | View |
| 2025-11-06 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-08-12 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-06-17 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2025-05-23 | Departure/Election of Directors; Appointment of Officers; Submission of Matters to a Vote of Securit | View | |
| 2025-05-19 | Other Events; Financial Statements and Exhibits | View | |
| 2025-05-13 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-05-12 | Entry into Material Definitive Agreement; Other Events; Financial Statements and Exhibits | Agreement | View |
| 2025-02-26 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2024-11-07 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2024-11-07 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2024-08-26 | Regulation FD Disclosure; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR